NHSBT Research and Development

Research & Development

Welcome to NHSBT Research and Development

The success of NHSBT's strategy to achieve long-term improvements in patient outcomes requires an innovative research programme. The effective application of novel technologies, processes and products drives the advancement of clinical practice, but this can only be accomplished by having an integrated R&D programme which supports organisational priorities. This requirement to undertake or commission R&D is within our statutory instrument.

Our R&D Programme is unique – within the public, private and academic sectors there are no other organisations capable of delivering an R&D programme that spans all our products and services. This is due to the combination of our partnerships with top class universities, our clearly defined operational objectives and our expertise in translation into new products, services and clinical guidelines.

Our world-leading R&D programme underpins our business strategies and guides international transfusion and transplantation practice. The 2015 – 2020 R&D Strategy sets out innovative plans in support of Blood 2020, Taking Organ Transplantation to 2020 and our operating strategies in Diagnostic and Therapeutic Services.

Call for applications for a clinical trial in acquired coagulopathy

NHSBT funds clinical trials and studies of blood components and alternative strategies in patients who may need transfusion support. We now invite calls in the area of acquired coagulopathy in any clinical setting where replacement therapy is currently given. Studies to test novel diagnostic markers are also welcome. The indicative budget is £200,000 per year for up to 4 years. Applications for prelimary/pilot studies are acceptable.

There will be a two-stage application process. The first, preliminary, application stage has now closed.

Selection Board shortlisting: 5th October 2016

Short-listed applicants notified and sent full application form: 10th October 2016

Deadline for full applications: 12th December 2016

Revisions and responses to reviewer comments: 7th March - 4th April 2017

R&D Committee meeting - funding decision made: 1st June 2017

For further information please contact Dr Nick Watkins, Assistant Director, Research and Development at nicholas.watkins@nhsbt.nhs.uk.